Humira biosimilar scripts take off

Prescribing of biosimilars for AbbVie's blockbuster rheumatoid arthritis drug Humira surged just over a week following a change in drug coverage by CVS Health.

Why it matters: It marked one of the first major efforts to push biosimilar adoption, Evercore ISI analyst Elizabeth Anderson told Axios.